Imugene Limited (IUGNF)
USD 0.02
(-23.91%)
USD 0.02
(-23.91%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -149.68 Million AUD | -294.78% |
| 2023 | -37.91 Million AUD | -0.12% |
| 2022 | -37.86 Million AUD | -105.19% |
| 2021 | -18.45 Million AUD | -75.63% |
| 2020 | -10.5 Million AUD | -35.14% |
| 2019 | -7.77 Million AUD | -97.66% |
| 2018 | -3.93 Million AUD | -56.93% |
| 2017 | -2.5 Million AUD | 8.21% |
| 2016 | -2.73 Million AUD | -11.88% |
| 2015 | -2.44 Million AUD | -15.35% |
| 2014 | -2.11 Million AUD | -35.68% |
| 2013 | -1.55 Million AUD | 50.23% |
| 2012 | -3.13 Million AUD | -854.06% |
| 2011 | 415.53 Thousand AUD | 127.07% |
| 2010 | -1.53 Million AUD | -336.06% |
| 2009 | 650.28 Thousand AUD | 134.03% |
| 2008 | -1.91 Million AUD | 17.07% |
| 2007 | -2.3 Million AUD | -5.35% |
| 2006 | -2.18 Million AUD | -21.9% |
| 2005 | -1.79 Million AUD | 15.19% |
| 2004 | -2.11 Million AUD | -402.65% |
| 2003 | 699.06 Thousand AUD | 189.39% |
| 2002 | -782 Thousand AUD | 80.65% |
| 2001 | -4.04 Million AUD | 8.54% |
| 2000 | -4.41 Million AUD | 10.37% |
| 1999 | -4.93 Million AUD | -8.45% |
| 1998 | -4.54 Million AUD | -108.34% |
| 1997 | -2.18 Million AUD | 48.59% |
| 1996 | -4.24 Million AUD | -98.78% |
| 1995 | -2.13 Million AUD | -144.0% |
| 1994 | -875 Thousand AUD | -460.08% |
| 1993 | 243 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -80.96 Million AUD | 0.0% |
| 2024 Q1 | -34.35 Million AUD | -67.42% |
| 2024 Q2 | -68.71 Million AUD | -100.0% |
| 2024 FY | -149.68 Million AUD | -294.78% |
| 2023 Q2 | -17.39 Million AUD | -100.0% |
| 2023 Q3 | -10.26 Million AUD | 41.0% |
| 2023 FY | -37.91 Million AUD | -0.12% |
| 2023 Q4 | -20.52 Million AUD | -100.0% |
| 2023 Q1 | -8.69 Million AUD | 62.25% |
| 2022 Q1 | -7.41 Million AUD | 40.16% |
| 2022 FY | -37.86 Million AUD | -105.19% |
| 2022 Q4 | -23.03 Million AUD | -100.0% |
| 2022 Q3 | -11.51 Million AUD | 22.34% |
| 2022 Q2 | -14.83 Million AUD | -100.0% |
| 2021 Q2 | -6.06 Million AUD | -100.0% |
| 2021 Q1 | -3.03 Million AUD | 46.98% |
| 2021 FY | -18.45 Million AUD | -75.63% |
| 2021 Q4 | -12.39 Million AUD | -100.0% |
| 2021 Q3 | -6.19 Million AUD | -2.2% |
| 2020 Q4 | -5.71 Million AUD | -100.0% |
| 2020 FY | -10.5 Million AUD | -35.14% |
| 2020 Q3 | -2.85 Million AUD | 40.33% |
| 2020 Q2 | -4.79 Million AUD | -100.0% |
| 2020 Q1 | -2.39 Million AUD | 44.63% |
| 2019 Q1 | -1.72 Million AUD | -49.91% |
| 2019 FY | -7.77 Million AUD | -97.66% |
| 2019 Q4 | -4.32 Million AUD | -100.0% |
| 2019 Q3 | -2.16 Million AUD | -25.43% |
| 2019 Q2 | -1.72 Million AUD | 0.0% |
| 2018 Q1 | -816.42 Thousand AUD | -61.02% |
| 2018 Q2 | -816.42 Thousand AUD | 0.0% |
| 2018 Q3 | -1.15 Million AUD | -40.91% |
| 2018 Q4 | -1.15 Million AUD | 0.0% |
| 2018 FY | -3.93 Million AUD | -56.93% |
| 2017 FY | -2.5 Million AUD | 8.21% |
| 2017 Q4 | -507.03 Thousand AUD | 0.0% |
| 2017 Q3 | -507.03 Thousand AUD | 32.06% |
| 2017 Q2 | -746.25 Thousand AUD | 0.0% |
| 2017 Q1 | -746.25 Thousand AUD | 12.1% |
| 2016 Q1 | -516.3 Thousand AUD | 25.71% |
| 2016 Q4 | -849.01 Thousand AUD | 0.0% |
| 2016 Q3 | -849.01 Thousand AUD | -64.44% |
| 2016 Q2 | -516.3 Thousand AUD | 0.0% |
| 2016 FY | -2.73 Million AUD | -11.88% |
| 2015 Q4 | -694.95 Thousand AUD | 0.0% |
| 2015 FY | -2.44 Million AUD | -15.35% |
| 2015 Q1 | -525.43 Thousand AUD | -74.02% |
| 2015 Q2 | -525.43 Thousand AUD | 0.0% |
| 2015 Q3 | -694.95 Thousand AUD | -32.26% |
| 2014 Q3 | -301.94 Thousand AUD | 60.06% |
| 2014 Q4 | -301.94 Thousand AUD | 0.0% |
| 2014 Q2 | -756.03 Thousand AUD | 0.0% |
| 2014 Q1 | -756.03 Thousand AUD | -367.32% |
| 2014 FY | -2.11 Million AUD | -35.68% |
| 2013 FY | -1.55 Million AUD | 50.23% |
| 2013 Q3 | -161.78 Thousand AUD | 0.0% |
| 2013 Q4 | -161.78 Thousand AUD | 0.0% |
| 2012 FY | -3.13 Million AUD | -854.06% |
| 2011 FY | 415.53 Thousand AUD | 127.07% |
| 2010 FY | -1.53 Million AUD | -336.06% |
| 2009 FY | 650.28 Thousand AUD | 134.03% |
| 2008 FY | -1.91 Million AUD | 17.07% |
| 2007 FY | -2.3 Million AUD | -5.35% |
| 2006 FY | -2.18 Million AUD | -21.9% |
| 2005 FY | -1.79 Million AUD | 15.19% |
| 2004 FY | -2.11 Million AUD | -402.65% |
| 2003 FY | 699.06 Thousand AUD | 189.39% |
| 2002 FY | -782 Thousand AUD | 80.65% |
| 2001 FY | -4.04 Million AUD | 8.54% |
| 2000 FY | -4.41 Million AUD | 10.37% |
| 1999 FY | -4.93 Million AUD | -8.45% |
| 1998 FY | -4.54 Million AUD | -108.34% |
| 1997 FY | -2.18 Million AUD | 48.59% |
| 1996 FY | -4.24 Million AUD | -98.78% |
| 1995 FY | -2.13 Million AUD | -144.0% |
| 1994 FY | -875 Thousand AUD | -460.08% |
| 1993 FY | 243 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bioxytran, Inc. | -4.28 Million USD | -3397.207% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -99.673% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -54647.419% |
| SQZ Biotechnologies Company | -79.46 Million USD | -88.363% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -5074.971% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 382.528% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 329.808% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -8121.82% |
| Marizyme, Inc. | -65.34 Million USD | -129.055% |
| Genus plc | 7.9 Million USD | 1994.69% |
| Pharming Group N.V. | -10.54 Million USD | -1319.042% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -6798.312% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -3934.261% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -1592.453% |
| ContraFect Corporation | -65.15 Million USD | -129.737% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -8564.801% |
| IMV Inc. | -36.48 Million USD | -310.244% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -1757.152% |
| ONE Bio Corp. | 8.67 Million USD | 1825.104% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -189.562% |
| Mesoblast Limited | -87.95 Million USD | -70.177% |
| MultiCell Technologies, Inc. | -380.07 USD | -39382260.881% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -3909.658% |
| Genscript Biotech Corporation | -95.47 Million USD | -56.771% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -23568.387% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -6186.8% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -2176.125% |
| Biomind Labs Inc. | -1.21 Million USD | -12226.295% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -4725.652% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -1793.949% |
| Skye Bioscience, Inc. | -37.64 Million USD | -297.613% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -7578.882% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -1274.257% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -999369.411% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -2963.418% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -2043.549% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -843.081% |
| Accustem Sciences Inc. | -3.74 Million USD | -3895.296% |
| EV Biologics, Inc. | -1.26 Million USD | -11712.526% |
| Q BioMed Inc. | -2.05 Million USD | -7194.043% |
| GB Sciences, Inc. | -1.36 Million USD | -10892.367% |
| Alpha Cognition Inc. | -13.77 Million USD | -986.802% |
| CSL Limited | 2.64 Billion USD | 105.665% |
| Agentix Corp. | -1.37 Million USD | -10792.107% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -150.615% |
| Enzolytics Inc. | -2.17 Million USD | -6776.072% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | -3.61 Million USD | -4046.275% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -4619.646% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -2473.045% |
| argenx SE | -295.05 Million USD | 49.27% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -139.11% |
| HST Global, Inc. | -146.21 Thousand USD | -102273.667% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 152835.244% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -8429.919% |
| Halberd Corporation | -79.67 Thousand USD | -187761.513% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 2261.579% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -4846.261% |
| Zenith Capital Corp. | -10.59 Million USD | -1312.614% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -3667.45% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -3510.295% |
| AVAX Technologies, Inc. | -6.41 Million USD | -2233.782% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -247548.955% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -7364.935% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -643908.859% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -4.76 Million USD | -3038.492% |
| Helix BioMedix, Inc. | -1.05 Million USD | -14073.528% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -3819.365% |
| Kadimastem Ltd | -3.3 Million USD | -4425.628% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | -8.48 Million USD | -1664.48% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -33812.789% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -11108.407% |
| LadRx Corporation | 400.44 Thousand USD | 37478.738% |
| Cell Source, Inc. | -5.32 Million USD | -2712.903% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -35926.018% |
| Regen BioPharma, Inc. | 1.02 Million USD | 14724.267% |
| Regen BioPharma, Inc. | 1.02 Million USD | 14724.267% |
| Affymax, Inc. | -14.42 Million USD | -937.719% |
| Mobile Lads Corp. | -2.26 Million USD | -6513.399% |
| Itoco Inc. | -1.86 Million USD | -7908.611% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -3269.26% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -8868.277% |
| International Stem Cell Corporation | -131 Thousand USD | -114159.953% |
| CytoDyn Inc. | -49.84 Million USD | -200.316% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -189289.924% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -65512.812% |
| Qrons Inc. | -789.34 Thousand USD | -18862.578% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -15797.603% |
| SYBLEU INC | -180.3 Thousand USD | -82915.651% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -7069.7% |
| Rebus Holdings, Inc. | -1.02 Million USD | -14574.563% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -9181.15% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -275696.984% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -5815.649% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -211.367% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -6980.442% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -19068.015% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -4624.764% |
| Neutra Corp. | -233.46 Thousand USD | -64012.625% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -637.67% |
| PureTech Health plc | -65.69 Million USD | -127.835% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -603.831% |
| IXICO plc | -1.17 Million USD | -12606.328% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -1407.812% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -162.009% |
| CSL Limited | 2.64 Billion USD | 105.665% |
| Cellectis S.A. | -103.17 Million USD | -45.076% |